COP vs PFE · P/E 19, rev $58.94B vs P/E 20, rev $62.58B
ConocoPhillips (COP) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
COP currently screens at market cap $135.49B and trailing P/E 18.8. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the COP and PFE stock pages for the full models.
Not investment advice.